Nicholas Hart

Nicholas Hart serves as Chief Executive Officer at IBSA Pharma Inc. and holds a board member position at Yaral Pharma, both since November 2022. Previously, Nicholas led Ascend Therapeutics as President and CEO from January 2020 to December 2022 and held the title of President, Specialty at Lupin Pharmaceuticals from May 2018 to January 2020. At Ferring Pharmaceuticals, Nicholas was Business Unit Head, overseeing the Reproductive Endocrinology business from September 2013 to May 2018. Nicholas's career also includes senior roles at URL Pharma as Senior Vice President of Marketing and Sales, and at Emisphere Technologies as Vice President of Strategy and Development. Earlier experience includes serving as Therapeutic Area Leader for Women's Healthcare at Organon Pharmaceuticals. Nicholas Hart earned an MBA in Finance and International Business from NYU Stern School of Business and attended the United States Military Academy at West Point.